Crohn’s Disease Study
To enroll in this study, please call (718)-818-2707.
Crohn’s Disease and Ulcerative Colitis are the main causes of inflammatory bowel disease for which available treatments may not be sufficient. If you suffer from these conditions and are ready to learn more about new treatment options, you may be interested in the studies at Richmond University Medical Center (RUMC). These studies will test a new medication that is not yet available to the public, and eligible participants are encouraged to enroll now.
The Diagnosis and Treatments of Inflammatory Bowel Disease
Millions of Americans are living with Crohn’s and ulcerative colitis disease, which cause inflammation in bowel tissue. While these conditions affect everyone differently, common symptoms include abdominal pain, bloody diarrhea, fatigue, weight loss and malnutrition. In some cases, the symptoms can be so debilitating that a person’s daily life is disrupted.
There is no known cure for these diseases at this time, and available medications may not help all those who need treatment. However, researchers are constantly seeking new treatment methods to support these individuals. By participating in a clinical study, patients who are currently unable to relieve their symptoms with current medication have an opportunity to seek newer treatments.
What to Expect
Clinical research studies allow doctors to test new drugs and treatment methods on human volunteers. The studies help advance science, give patients access to new medicine, and provide hope for future patients. All participants are monitored closely to ensure their safety. Before participating, you will have a chance to sit down with the doctors and discuss the benefits and possible risks, as well as study procedures. There will also be time to ask any questions you might have.
Once you begin the study, you will be required to make regular visits to the clinic, where the staff will perform tests and assessments to see how your body is responding to the medication. The visiting times are flexible to accommodate your schedule.
There is no cost to participate, and compensation may be available.
Who Should Enroll
All patients with moderate-to-severe symptoms and proven diagnosis of Crohn’s disease and ulcerative colitis are welcome to volunteer for the study. In order to qualify, you must meet the following criteria:
- 16 to 80 years of age
- Diagnosed with Crohn’s disease or ulcerative colitis
- Diagnosed at least 3 months ago
- Currently experiencing symptoms
- At least onemedication does not work well for you
How to Enroll
If you are interested in these studies at the Richmond University Medical Center, call (718)-818-2707 or contact the Clinical Research Department at email@example.com. We will provide answers to your questions and help you decide whether or not you are a good candidate for one of the five studies.